# FDA recall D-925-2013

> **Nexus Pharmaceuticals Inc** · Class II · drug recall initiated 2013-08-01.

## Product

Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufactured in the USA for Nexus Pharmaceuticals Inc, Lincolnshire, IL 60069,  NDC 14789-300-02

## Reason for recall

Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-925-2013
- **Recalling firm:** Nexus Pharmaceuticals Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-08-01
- **Report date:** 2013-09-04
- **Termination date:** 2016-02-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Vernon Hills, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-925-2013

## Citation

> AI Analytics. FDA recall D-925-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-925-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*